Laohavisudhi, F.; Chunchai, T.; Ketchaikosol, N.; Thosaporn, W.; Chattipakorn, N.; Chattipakorn, S.C.
Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands. Diagnostics 2022, 12, 1275.
https://doi.org/10.3390/diagnostics12051275
AMA Style
Laohavisudhi F, Chunchai T, Ketchaikosol N, Thosaporn W, Chattipakorn N, Chattipakorn SC.
Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands. Diagnostics. 2022; 12(5):1275.
https://doi.org/10.3390/diagnostics12051275
Chicago/Turabian Style
Laohavisudhi, Fonthip, Titikorn Chunchai, Natnicha Ketchaikosol, Wacharaporn Thosaporn, Nipon Chattipakorn, and Siriporn C. Chattipakorn.
2022. "Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands" Diagnostics 12, no. 5: 1275.
https://doi.org/10.3390/diagnostics12051275
APA Style
Laohavisudhi, F., Chunchai, T., Ketchaikosol, N., Thosaporn, W., Chattipakorn, N., & Chattipakorn, S. C.
(2022). Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands. Diagnostics, 12(5), 1275.
https://doi.org/10.3390/diagnostics12051275
